FDA.reportPublic FDA data

ELAGOLIX Pharmacologic Class Indexing

Class set ID
3cc9bf90-f95a-4ade-9b5b-92849c3a8a8b
Version
2
Effective date
20210810
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use ORIAHNN safely and effectively. See full prescribing information for ORIAHNN. ORIAHNN ® (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules), co-packaged for oral use Initial U.S. Approval: 2020AbbVie Inc.2025121941
These highlights do not include all the information needed to use ORILISSA safely and effectively. See full prescribing information for ORILISSA. ORILISSA ® (elagolix) tablets, for oral use Initial U.S. Approval: 2018AbbVie Inc.20251219111